The Well, hello, my friends, and welcome to the worldwide broadcast of the Ted and Austin Brower show, bringing you the latest world news and health research.

Hope you guys are having a fantastic day today.

And we got dad with us today on the show.

So it's going to be a very interesting show.

A lot of different stuff we're going to cover.

And hope you guys enjoyed yesterday's solo show.

I went into detail on a lot of stuff that's happening right now with this shot that's going on behind the scenes that nobody is wanting to talk about in the mainstream media, especially what's happening with the clinical trials, the 190-page clinical trial data, the FDA finally released about these shots tested on these six-month-olds and how insane what we're seeing is right now.

I'll be on Doug's show tonight and I'll talk about it in a detail.

And what's interesting yesterday, I also brought up briefly how the FDA and Pfizer were

working together to make sure that there will be no more clinical trials ever on the RNA gene

therapy shots.

And sure enough, if I didn't call it right before it happened, Reuters put out an article

yesterday.

The title of the article is this, FDA will not require clinical trial data to authorize

redesign COVID boosters.

The U.S. FDA stated that they will not require Pfizer- Moderna to submit clinical trial data on the COVID-19 vaccines modified to protect against the B4-B-5 Omnicron subvariance.

FDA top official has said Dr. Peter Marks, who's the senior official overseen vaccines at the U.S. FDA administration.

They said on Thursday they recommend the COVID-19 vaccine manufacturers change the design of

their booster shots beginning this fall to include components tailored to combat the currently

dominant Omnicron, B.A.4, and B..5 sub-varians that I talked about yesterday that they're saying

now are primarily in all vaccinated individuals that are showing these symptoms are with these

new variants that have now completely mutated and sidestep any type of immunity that may

...